Found: 32
Select item for more details and to access through your institution.
Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 3, p. 347, doi. 10.1007/s10637-016-0347-6
- By:
- Publication type:
- Article
Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 306, doi. 10.3892/ol.2017.6118
- By:
- Publication type:
- Article
Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Influence of the distance between home and the hospital on patients with surgically resected non-small-cell lung cancer.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2016, v. 49, n. 3, p. 842, doi. 10.1093/ejcts/ezv253
- By:
- Publication type:
- Article
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
- By:
- Publication type:
- Article
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 731, doi. 10.1007/s10147-019-01431-z
- By:
- Publication type:
- Article
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
- Published in:
- Surgery Today, 2019, v. 49, n. 3, p. 197, doi. 10.1007/s00595-018-1751-7
- By:
- Publication type:
- Article
Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer.
- Published in:
- Surgery Today, 2016, v. 46, n. 4, p. 430, doi. 10.1007/s00595-015-1200-9
- By:
- Publication type:
- Article
The mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.
- Published in:
- Surgery Today, 2014, v. 44, n. 3, p. 478, doi. 10.1007/s00595-013-0589-2
- By:
- Publication type:
- Article
Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 4, p. 1227, doi. 10.1007/s00432-020-03413-5
- By:
- Publication type:
- Article
Elements of End-of-Life Discussions Associated With Patients' Reported Outcomes and Actual End-of-Life Care in Patients With Pretreated Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 2, p. e282, doi. 10.1093/oncolo/oyad245
- By:
- Publication type:
- Article
Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 982, doi. 10.1093/oncolo/oyac178
- By:
- Publication type:
- Article
Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640
- By:
- Publication type:
- Article
Genetic Profiling of Non‐Small Cell Lung Cancer at Development of Resistance to First‐ or Second‐Generation EGFR‐TKIs by CAPP‐Seq Analysis of Circulating Tumor DNA.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1022, doi. 10.1634/theoncologist.2019-0101
- By:
- Publication type:
- Article
A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
- By:
- Publication type:
- Article
The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
LKB1 Mutations Frequently Detected in Mucinous Bronchioloalveolar Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 9, p. 1132, doi. 10.1093/jjco/hyr102
- By:
- Publication type:
- Article
Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 13, p. 1983, doi. 10.1111/1759-7714.14001
- By:
- Publication type:
- Article
Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 9, p. 1779, doi. 10.1111/1759-7714.13143
- By:
- Publication type:
- Article
Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2205, doi. 10.1007/s00262-023-03393-8
- By:
- Publication type:
- Article
The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08630-z
- By:
- Publication type:
- Article
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 3, p. 619, doi. 10.1007/s00280-013-2234-6
- By:
- Publication type:
- Article
A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0382-3
- By:
- Publication type:
- Article
Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0322-2
- By:
- Publication type:
- Article
Feasibility of cisplatin/pemetrexed with 15 mg/kg bevacizumab for the treatment of patients with advanced non-squamous non-small cell lung cancer.
- Published in:
- Oncology Letters, 2015, v. 9, n. 6, p. 2577, doi. 10.3892/ol.2015.3086
- By:
- Publication type:
- Article
c-Kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Prognostic impact and gene expression analysis of peri‐tumoral alveolar macrophage in resected lung adenocarcinoma.
- Published in:
- Cancer Science, 2023, v. 114, n. 8, p. 3423, doi. 10.1111/cas.15848
- By:
- Publication type:
- Article
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset*.
- Published in:
- Cancer Science, 2021, v. 112, n. 12, p. 5000, doi. 10.1111/cas.15144
- By:
- Publication type:
- Article
First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4480, doi. 10.1111/cas.14647
- By:
- Publication type:
- Article
Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.
- Published in:
- Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820
- By:
- Publication type:
- Article
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.
- Published in:
- Cancer Science, 2017, v. 108, n. 9, p. 1843, doi. 10.1111/cas.13309
- By:
- Publication type:
- Article